Capital Flow Monitor · Sponsors · CIK 1781983
Aprea Therapeutics, Inc.
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902 · 215-948-4119
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$5.8M
Sold
$3.1M
% sold
52.8%
Investors
8
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-29 | D ·current | 506(b) | $5.8M | $3.1M | 52.8% | 8 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Oren Gilad — Executive Officer / Director, Doylestown, PA
- John P. Hamill — Executive Officer, Doylestown, PA
- Richard Peters — Director, Doylestown, PA
- Jean-Pierre Bizzari — Director, Doylestown, PA
- Marc Duey — Director, Doylestown, PA
- Michael Grissinger — Director, Doylestown, PA
- Gabriela Gruia — Director, Doylestown, PA
- John B. Henneman — Director, Doylestown, PA
- Rifat Pamukcu — Director, Doylestown, PA
- Bernd Seizinger — Director, Doylestown, PA
Placement agents
- Maxim Group Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.